The Journal of surgical research · 2025
Delayed Treatment Associated With Worse Survival in High-grade Undifferentiated Pleomorphic Sarcoma.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
O'Brien Aidan C, Farmer Sawyer H, Koyada Prajeeth K, Feustel Paul J, DiCaprio Matthew R
Аннотация
INTRODUCTION: Time to treatment initiation is linked to survival in several malignancies. However, its role in soft tissue sarcomas, particularly high-grade, undifferentiated pleomorphic sarcoma, remains unclear. Evaluation of individual histologic subtypes enables a more patient-centered treatment approach. The purpose of this study was to evaluate the association between time to treatment initiation and survival in patients with high-grade, localized undifferentiated pleomorphic sarcoma.
METHODS: Patients diagnosed with localized, high-grade undifferentiated pleomorphic sarcoma between 2004 and 2021 were identified retrospectively from the National Cancer Database. After excluding noneligible cases, 6220 patients were included. Kaplan-Meier and multivariable Cox proportional hazards models were used to evaluate the association between time to treatment initiation and overall survival.
RESULTS: Treatment initiation after 4 weeks was associated with significantly lower 5-year survival (P < 0.001). On multivariable analysis of extremity and trunk tumors, prolonged time to treatment initiation was independently associated with worse survival (hazard ratio [HR] = 1.01 per week; 95% confidence interval (CI) = 1.00-1.03; P = 0.013). However, this association was not observed in tumors of the head and neck (HR = 1.00; 95% CI = 0.95-1.05; P = 0.837) or abdomen and pelvis (HR = 1.00; 95% CI = 0.97-1.03; P = 0.995).
CONCLUSIONS: Prolonged time-to-treatment initiation is independently associated with decreased survival in patients with localized, high-grade undifferentiated pleomorphic sarcoma of the extremity and trunk. The time-to-treatment initiation appears to be increasing over time, which may be driven by evolving diagnostic practices and insurance-related delays.
METHODS: Patients diagnosed with localized, high-grade undifferentiated pleomorphic sarcoma between 2004 and 2021 were identified retrospectively from the National Cancer Database. After excluding noneligible cases, 6220 patients were included. Kaplan-Meier and multivariable Cox proportional hazards models were used to evaluate the association between time to treatment initiation and overall survival.
RESULTS: Treatment initiation after 4 weeks was associated with significantly lower 5-year survival (P < 0.001). On multivariable analysis of extremity and trunk tumors, prolonged time to treatment initiation was independently associated with worse survival (hazard ratio [HR] = 1.01 per week; 95% confidence interval (CI) = 1.00-1.03; P = 0.013). However, this association was not observed in tumors of the head and neck (HR = 1.00; 95% CI = 0.95-1.05; P = 0.837) or abdomen and pelvis (HR = 1.00; 95% CI = 0.97-1.03; P = 0.995).
CONCLUSIONS: Prolonged time-to-treatment initiation is independently associated with decreased survival in patients with localized, high-grade undifferentiated pleomorphic sarcoma of the extremity and trunk. The time-to-treatment initiation appears to be increasing over time, which may be driven by evolving diagnostic practices and insurance-related delays.